Loading…
Renol Polychem (RNPL)₹61.40+4.07%Specialty Chemicals
In the Mar 2026 quarter (consolidated), Renol Polychem reported sales of ₹50.13 Cr, up 49.3% from Mar 2025, and net profit of ₹5.86 Cr, up 110.0% year on year. For the year to Mar 2026, sales were ₹90.37 Cr and net profit ₹8.23 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales | 33.57 | 50.13 |
| Expenses | 29.31 | 41.42 |
| Operating Profit | 4.11 | 8.44 |
| OPM % | 12.3% | 16.9% |
| Other Income | 0.10 | 0.10 |
| Interest | 0.39 | 0.10 |
| Depreciation | 0.09 | 0.46 |
| Profit before tax | 3.72 | 7.94 |
| Tax % | 24.9% | 26.5% |
| Net Profit | 2.79 | 5.86 |
| EPS (Rs) | 5.09 | 4.85 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales | 62.55 | 90.37 |
| Expenses | 55.10 | 78.09 |
| Operating Profit | 7.16 | 11.78 |
| OPM % | 11.5% | 13.1% |
| Other Income | 0.25 | 0.23 |
| Interest | 0.59 | 0.28 |
| Depreciation | 0.15 | 0.55 |
| Profit before tax | 6.65 | 11.12 |
| Tax % | 25.0% | 26.2% |
| Net Profit | 4.99 | 8.23 |
| EPS (Rs) | 9.08 | 6.81 |
| Dividend payout % | 0.0% | 0.0% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 5.48 | 12.07 |
| Reserves | 7.85 | 96.38 |
| Borrowings | 6.97 | 17.15 |
| Other Liabilities | 3.14 | 75.26 |
| Total Liabilities | 23.44 | 201 |
| Fixed Assets | 0.35 | 34.54 |
| CWIP | 0.00 | 0.00 |
| Investments | 0.31 | 7.46 |
| Other Assets | 22.78 | 159 |
| Inventories | 9.01 | 51.01 |
| Trade receivables | 8.97 | 64.70 |
| Cash & equivalents | 3.01 | 11.03 |
| Total Assets | 23.44 | 201 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from operating activity | −1.27 | −40.12 |
| Cash from investing activity | −0.54 | −60.57 |
| Cash from financing activity | 3.79 | 109 |
| Net cash flow | 1.96 | 8.19 |
| Capex | 0.09 | 22.34 |
| Free cash flow | −1.39 | −62.65 |
| CFO / OP % | 10.0% | −317.0% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor days | 52 | 264 |
| Inventory days | 64 | 258 |
| Days payable | 8 | 292 |
| Cash conversion cycle | 109 | 231 |
| Working capital days | 56 | 211 |
| ROCE % | — | 14.5% |
For the Mar 2026 quarter, Renol Polychem reported sales of ₹50.13 Cr, up 49.3% year on year and net profit of ₹5.86 Cr, up 110.0% year on year. The operating margin was 16.9%.
Renol Polychem's sales for the year to Mar 2026 were ₹90.37 Cr.
Net profit for the year to Mar 2026 was ₹8.23 Cr. Earnings per share over the same trailing period were ₹6.81.
Renol Polychem reported borrowings of ₹17.15 Cr at Mar 2026, against cash and equivalents of ₹11.03 Cr.
Cash from operations was −₹40.12 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹62.65 Cr.